TuHURA Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | |||
EBITDA | -9,523 | ||
EBIT | -9,875 | -6,764 | |
Net Income | -23,296 | -9,523 | -6,664 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -11,086 | -11,034 | -4,781 |
Cash | 2,697 | 8,512 | 6,219 |
Basic Shares | 51,254 | 44,555 | 43,680 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -116 | |||
EBITDA | -17,427 | -29,120 | -9,560 | -6,006 |
EBIT | -17,544 | -29,298 | -9,933 | -6,387 |
Net Income | -21,682 | -29,316 | -9,367 | -7,016 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,786 | -12,030 | -7,544 | -6,566 |
Cash | 12,657 | 3,665 | 14,252 | 5,546 |
Basic Shares | 18,662 | 752 | 46 | 27 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.14 |
2025-06-30 | -$0.21 |
2025-03-31 | -$0.15 |
2024-12-31 | -$0.14 |
